Turns out the Trump administration's big Affordable Care Act regulation packs a bit more punch than we realized at first.
How it works: Some of the rule's technical changes will end up requiring people to pay more for their coverage, while rolling back the cost of federal premium subsidies. People who get a subsidy under the ACA have to pay a certain percentage of their income for insurance premiums; the government picks up the rest.
The number of price increases on brand-name drugs fell by about half from 2015 through 2018, according to data provided to Axios and compiled by 46brooklyn Research, a nonprofit firm that tracks drug prices.
Yes, but: Several companies still raised list prices frequently and at rates well above inflation, and many medications that saw higher prices had already lost patent protection or are nearing a patent expiration.
